Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria
Clinical trial NCT04300309 · TERMINATED
Trial details
- NCT number
- NCT04300309
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2023-07-02
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.